About me
Lisa Wright brings over a decade of experience in the pharmaceutical and biopharmaceutical industry. She has held multiple positions with a primary focus on regulatory affairs and policy. In her current role at Novo Nordisk, Lisa engages with the FDA on regulatory CMC and device issues, advocating for advancements in areas such as advanced manufacturing, platform manufacturing technologies, and combination products. Before joining Novo Nordisk, she worked with several consulting firms, including Booz Allen Hamilton, where she supported clients at both CDER and CDRH within the FDA. She holds a Master of Science in Bioinformatics from Johns Hopkins University and a Bachelor of Science in Biology from University of Maryland, College Park.
